Details for Patent: 6,730,679
✉ Email this page to a colleague
Summary for Patent: 6,730,679
Title: | Pharmaceutical formulations |
Abstract: | Pharmaceutical formulations containing HIV protease inhibitors, specifically including 3S-[3R*(1R*,2S*)]-[3-[[(4-aminophenyl)sulphonyl](2-methylpropyl)-amino]-2- hydroxy-1-phenylmethyl)propyl]carbamic acid, tetrahydro-3-furanyl ester (alternatively known as VX 478 or 141W94), and a tocopherol, and their use in medical therapy are described. |
Inventor(s): | Roy; Arup K. (Greenville, NC), Tillman; Lloyd Gary (Carlsbad, CA) |
Assignee: | SmithKline Beecham Corporation (Philadelphia, PA) |
Application Number: | 08/820,848 |
Patent Claim Types: see list of patent claims | Formulation; Compound; Dosage form; |
Drugs Protected by US Patent 6,730,679
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 6,730,679
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
African Regional IP Organization (ARIPO) | 1150 | ⤷ Sign Up | |||
African Regional IP Organization (ARIPO) | 9801343 | ⤷ Sign Up | |||
Argentina | 006345 | ⤷ Sign Up | |||
Austria | 230602 | ⤷ Sign Up | |||
Australia | 2159197 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |